Pharma & Biopharma Manufacturing
CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...
November 14, 2023 | News
In an exclusive interview by BioPharma APAC , Hong Chow, Executive Vice President and Head of China & International for Merck's Healthcare business, pr...
November 14, 2023 | News
MasterControl, a leading provider of quality management and next generation manufacturing execution software, announced a major milestone with over 150 cus...
November 13, 2023 | News
Hilleman Laboratories, an organisation with a mission to develop affordable vaccines and biologics against infectious diseases with unmet medical need, off...
November 09, 2023 | News
“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, ...
November 09, 2023 | News
Historical Context Australia has a long history of pharmaceutical manufacturing dating back to the early 20th century. The industry primarily focused on t...
November 08, 2023 | Analysis
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology...
November 07, 2023 | News
Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it was setting up ...
October 31, 2023 | News
Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities A scalabl...
October 30, 2023 | News
Sirio Pharma Co., Ltd. (Sirio), a leading global CDMO, is pleased to announce the addition of new gummy manufacturing capabilities at its Best Formulations...
October 20, 2023 | News
WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...
October 17, 2023 | News
Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint Newly formed KKR platform Frontier Biosolutio...
October 16, 2023 | News
ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...
October 13, 2023 | News
The agreement will significantly advance CSL's Scope 1 & 2 emissions reductions with all electricity used by CSL's Australian manufacturing sites ...
October 12, 2023 | News
Most Read
Bio Jobs
News
Editor Picks